Highlight selection of radiochemistry and radiopharmacy developments by editorial board

Jun Toyohara; Danielle Vugts; Oliver C Kiss; Sergio Todde; Xiang-Guo Li; Zhibo Liu; Zhi Yang; Nic Gillings; Emiliano Cazzola; Wiktor Szymanski; Nick van der Meulen; Raymond Reilly; Carlotta Taddei; Ralf Schirrmacher; Zijing Li; Yohannes Jorge Lagebo; Naoual Bentaleb; Marta de Souza Albernaz; Suzanne Lapi; Caterina Ramogida; Archana Mukherjee; Javier Ajenjo; Winnie Deuther-Conrad; Cécile Bourdeau

doi:10.1186/s41181-024-00268-w

Highlight selection of radiochemistry and radiopharmacy developments by editorial board

Jun Toyohara, Danielle Vugts, Oliver C Kiss^*, Sergio Todde, Xiang-Guo Li, Zhibo Liu, Zhi Yang, Nic Gillings, Emiliano Cazzola, Wiktor Szymanski, Nick van der Meulen, Raymond Reilly, Carlotta Taddei, Ralf Schirrmacher, Zijing Li, Yohannes Jorge Lagebo, Naoual Bentaleb, Marta de Souza Albernaz, Suzanne Lapi, Caterina RamogidaArchana Mukherjee, Javier Ajenjo, Winnie Deuther-Conrad, Cécile Bourdeau

^*Corresponding author for this work

Department of Clinical Physiology, Nuclear Medicine & PET

Abstract

BACKGROUND: The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biannual highlight commentary to update the readership on trends in the field of radiopharmaceutical development.

MAIN BODY: This selection of highlights provides commentary on 24 different topics selected by each coauthoring Editorial Board member addressing a variety of aspects ranging from novel radiochemistry to first-in-human application of novel radiopharmaceuticals.

CONCLUSION: Trends in radiochemistry and radiopharmacy are highlighted. Hot topics cover the entire scope of EJNMMI Radiopharmacy and Chemistry, demonstrating the progress in the research field in many aspects.

Original language	English
Article number	42
Journal	EJNMMI radiopharmacy and chemistry
Volume	9
Issue number	1
Pages (from-to)	42
ISSN	2365-421X
DOIs	https://doi.org/10.1186/s41181-024-00268-w
Publication status	Published - 16 May 2024

Access to Document

10.1186/s41181-024-00268-w

Cite this

Toyohara, J., Vugts, D., Kiss, O. C., Todde, S., Li, X.-G., Liu, Z., Yang, Z., Gillings, N., Cazzola, E., Szymanski, W., Meulen, N. V. D., Reilly, R., Taddei, C., Schirrmacher, R., Li, Z., Lagebo, Y. J., Bentaleb, N., Souza Albernaz, M. D., Lapi, S., ... Bourdeau, C. (2024). Highlight selection of radiochemistry and radiopharmacy developments by editorial board. EJNMMI radiopharmacy and chemistry, 9(1), 42. Article 42. https://doi.org/10.1186/s41181-024-00268-w

Toyohara, J, Vugts, D, Kiss, OC, Todde, S, Li, X-G, Liu, Z, Yang, Z, Gillings, N, Cazzola, E, Szymanski, W, Meulen, NVD, Reilly, R, Taddei, C, Schirrmacher, R, Li, Z, Lagebo, YJ, Bentaleb, N, Souza Albernaz, MD, Lapi, S, Ramogida, C, Mukherjee, A, Ajenjo, J, Deuther-Conrad, W & Bourdeau, C 2024, 'Highlight selection of radiochemistry and radiopharmacy developments by editorial board', EJNMMI radiopharmacy and chemistry, vol. 9, no. 1, 42, pp. 42. https://doi.org/10.1186/s41181-024-00268-w

@article{49b04bfa33bd42aaa43d96c5675c9d0a,

title = "Highlight selection of radiochemistry and radiopharmacy developments by editorial board",

abstract = "BACKGROUND: The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biannual highlight commentary to update the readership on trends in the field of radiopharmaceutical development.MAIN BODY: This selection of highlights provides commentary on 24 different topics selected by each coauthoring Editorial Board member addressing a variety of aspects ranging from novel radiochemistry to first-in-human application of novel radiopharmaceuticals.CONCLUSION: Trends in radiochemistry and radiopharmacy are highlighted. Hot topics cover the entire scope of EJNMMI Radiopharmacy and Chemistry, demonstrating the progress in the research field in many aspects.",

author = "Jun Toyohara and Danielle Vugts and Kiss, {Oliver C} and Sergio Todde and Xiang-Guo Li and Zhibo Liu and Zhi Yang and Nic Gillings and Emiliano Cazzola and Wiktor Szymanski and Meulen, {Nick van der} and Raymond Reilly and Carlotta Taddei and Ralf Schirrmacher and Zijing Li and Lagebo, {Yohannes Jorge} and Naoual Bentaleb and {Souza Albernaz}, {Marta de} and Suzanne Lapi and Caterina Ramogida and Archana Mukherjee and Javier Ajenjo and Winnie Deuther-Conrad and C{\'e}cile Bourdeau",

note = "{\textcopyright} 2024. The Author(s).",

year = "2024",

month = may,

day = "16",

doi = "10.1186/s41181-024-00268-w",

language = "English",

volume = "9",

pages = "42",

journal = "EJNMMI radiopharmacy and chemistry",

issn = "2365-421X",

publisher = "SpringerOpen",

number = "1",

}

TY - JOUR

T1 - Highlight selection of radiochemistry and radiopharmacy developments by editorial board

AU - Toyohara, Jun

AU - Vugts, Danielle

AU - Kiss, Oliver C

AU - Todde, Sergio

AU - Li, Xiang-Guo

AU - Liu, Zhibo

AU - Yang, Zhi

AU - Gillings, Nic

AU - Cazzola, Emiliano

AU - Szymanski, Wiktor

AU - Meulen, Nick van der

AU - Reilly, Raymond

AU - Taddei, Carlotta

AU - Schirrmacher, Ralf

AU - Li, Zijing

AU - Lagebo, Yohannes Jorge

AU - Bentaleb, Naoual

AU - Souza Albernaz, Marta de

AU - Lapi, Suzanne

AU - Ramogida, Caterina

AU - Mukherjee, Archana

AU - Ajenjo, Javier

AU - Deuther-Conrad, Winnie

AU - Bourdeau, Cécile

PY - 2024/5/16

Y1 - 2024/5/16

N2 - BACKGROUND: The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biannual highlight commentary to update the readership on trends in the field of radiopharmaceutical development.MAIN BODY: This selection of highlights provides commentary on 24 different topics selected by each coauthoring Editorial Board member addressing a variety of aspects ranging from novel radiochemistry to first-in-human application of novel radiopharmaceuticals.CONCLUSION: Trends in radiochemistry and radiopharmacy are highlighted. Hot topics cover the entire scope of EJNMMI Radiopharmacy and Chemistry, demonstrating the progress in the research field in many aspects.

AB - BACKGROUND: The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biannual highlight commentary to update the readership on trends in the field of radiopharmaceutical development.MAIN BODY: This selection of highlights provides commentary on 24 different topics selected by each coauthoring Editorial Board member addressing a variety of aspects ranging from novel radiochemistry to first-in-human application of novel radiopharmaceuticals.CONCLUSION: Trends in radiochemistry and radiopharmacy are highlighted. Hot topics cover the entire scope of EJNMMI Radiopharmacy and Chemistry, demonstrating the progress in the research field in many aspects.

UR - http://www.scopus.com/inward/record.url?scp=85193463663&partnerID=8YFLogxK

U2 - 10.1186/s41181-024-00268-w

DO - 10.1186/s41181-024-00268-w

M3 - Review

C2 - 38753262

SN - 2365-421X

VL - 9

SP - 42

JO - EJNMMI radiopharmacy and chemistry

JF - EJNMMI radiopharmacy and chemistry

IS - 1

M1 - 42

ER -

Highlight selection of radiochemistry and radiopharmacy developments by editorial board

Abstract

Access to Document

Other files and links

Fingerprint

Cite this